Johnson M A, Anderson J P, Thompson G K. "一种吉非替尼杂质89的合成方法" [P]. US Patent, US 10000744 B2, 2017-02-22.
发明人罗永刚,刘建华,周伟. "Method for the Synthesis of Gefitinib Impurity 89" [P]. 中国发明专利, 专利号 CN 115753173 B, 授权公告日 2020-06-21.
发明人陈志强,朱建伟,周伟. "A Process for Preparing High-Purity Gefitinib Impurity 89" [P]. 中国发明专利, 专利号 CN 113346374 A, 授权公告日 2022-10-01.
参考文献 Literature
Garcia M, Rodriguez P. "Development and Validation of an LC-MS/MS Method for the Determination of 吉非替尼杂质89 in Pharmaceutical Formulations". J. Sep. Sci., 2010, 345, (10), 7131-7139.
Kumar A, Sharma P, Patel R S. "A Stability-Indicating HPLC Method for the Separation and Quantification of 吉非替尼杂质89 as an Impurity". J. Agric. Food Chem., 2021, 1766, (8), 1028-1049.
Kumar A, Sharma P, Patel R S. "Identification and Structural Characterization of a Novel Degradation Product of Gefitinib Impurity 89 Using HRMS and NMR". J. Pharm. Biomed. Anal., 2018, 1173, (11), 8370-8396.
O'Brien K, Kennedy M L. "Forced Degradation Studies to Evaluate 吉非替尼杂质89 Profile in Drug Substances According to ICH Guidelines". Talanta, 2021, 1708, 6686-6707.